PubMed Health⌕ Search

Biomedical subjects

R D Kulkarni

Publications and source records attributed to R D Kulkarni.

At least 37 records · Page 2Linked to original sources

Transcriptional and posttranscriptional components of psbA response to high light intensity in Synechococcus sp. strain PCC 7942.

The psbA genes, which encode the D1 protein of photosystem II, constitute a multigene family in the cyanobacterium Synechococcus sp. strain PCC 7942. Levels of messages from the three psbA genes change rapidly when cells are shifted from low-light to high-light conditions: the psbAI message level drops, whereas psbAII and psbAIII message levels increase dramatically. We examined the potential contributions of transcriptional and posttranscriptional processes in these high-light responses by subjecting cells that had been grown in a turbidostat at a standard light intensity (130 microeinsteins [microE] m-2 s-1) to either the same or a higher light intensity (500 microE m-2 s-1) in the presence or absence of rifampin. Northern (RNA blot) analysis of RNA isolated from cells subjected to high light showed that the increases in psbAII and psbAIII transcripts were blocked by rifampin. This suggests a transcriptional induction of these genes at high light intensities. Increased mRNA stability does not contribute to their accumulation in high-light conditions, since their half-life values did not increase relative to the half-lives measured at the standard light intensity. The rate of disappearance of the psbAI transcript in cells shifted to high light was diminished when either transcription or translation was blocked by rifampin or chloramphenicol, suggesting that accelerated degradation of the message requires de novo synthesis of a protein factor. When rifampin was added 10 min after the shift to high light intensity rather than before the shift, psbAI and psbAIII messages, but not the psbAII message, decayed at a faster rate. Susceptibility of the psbAIII transcript to the high-light-induced factor was also demonstrated by addition of chloramphenicol prior to the shaft to high light. psbAIII transcript levels went up more than twofold higher in chloramphenicol-treated cells than in untreated cells, whereas psbAII transcript levels were affected by the inhibitor. These experiments provide evidence that either new or increased synthesis of a degradation factor which affects a subset of Synechococcus transcripts occurs in cells subjected to high light intensity.

Adaptation, Biological↗

Alcohol hangover and Liv.52.

Ethanol and acetaldehyde levels in blood and urine have been evaluated in 9 volunteers following administration of Liv.52 and placebo on the evening of the study and on the following morning. On the following morning the volunteers scored their symptoms and completed visual analogue scales. Single dose and multiple dose studies were done. Liv.52 produced a considerable reduction in blood and urine levels of ethanol and acetaldehyde after 12 h. It is possible that Liv.52 prevents the binding of acetaldehyde, bringing about higher initial blood levels followed by rapid elimination. It reduced the hangover symptoms.

Acetaldehyde↗

Effect of Liv.52, a herbal preparation, on absorption and metabolism of ethanol in humans.

In 8 social drinkers, the effect of a single dose of Liv.52 or placebo on ethanol absorption has been studied after ingestion of 30 ml whisky in 5 min. The t1/2 absorption with Liv.52 was 3.62 min, significantly less than after placebo, 6.29 min. The peak concentration after Liv.52 (49.9 mg.100 ml-1) was significantly higher than with placebo (40.5 mg.100 ml-1). Whisky 120 ml consumed by regular alcohol users in 1 h, before and following 15 days of Liv.52 treatment produced significantly higher ethanol levels at 2, 3 and 4 h and significantly lower acetaldehyde levels at 3 and 4 h after Liv.52 treatment. Liv.52 enhanced the rate of absorption of ethanol and rapidly reduced acetaldehyde levels, which may explain its hepatoprotective effect on ethanol-induced liver damage.

Acetaldehyde↗

Effect of Abana on ventricular function in ischemic heart disease.

Mechanocardiography has been in use to evaluate ventricular function and the cardiac effect of drugs. Twenty-five patients with ischemic heart disease (IHD) and 25 patients with IHD and mild hypertension (HTN) were enrolled in a double-blind, placebo controlled study of Abana. Half the patients in each group received Abana--a formulation based on Ayurvedic principles--and the other half received a placebo in a randomized manner. The effect of Abana was evaluated by means of LV apex cardiogram (ACG), phonocardiogram and carotid pulse tracing and ECG (mechanocardiography) before and at the end of 8 weeks of treatment. As compared to placebo, Abana significantly reduced the frequency and severity of anginal episodes, as judged by clinical improvement and nitrate consumption. Significant improvement in ventricular function was observed as reflected by a decrease in ACG A amplitude and A wave duration, along with a significant increase in LV ejection fraction and VCF. The decrease in double and triple products reflected decreased MVO2. A significant fall in diastolic blood pressure was noted in patients with mild hypertension. Abana seems to reduce preload and afterload and improve diastolic function and pump function, which may be responsible for the beneficial effects of Abana in ischemic heart disease.

Adult↗

Incidence of hepatitis B surface antigen in liver diseases and voluntary blood donors.

A total of 5,606 samples were collected during January 1978 to December 1983. Out of which 4,900 were of voluntary blood donors, 564 of acute hepatitis, 130 of liver cirrhosis and 12 from hepatocellular carcinoma cases. All these samples were studied by counter immune-electro-osmophoresis (CIEP) for the presence of hepatitis B surface antigen (HBsAg). The HBsAg were detected in 40 samples from voluntary donors (0.8%), 122 cases of acute hepatitis (21.6%), 20 cases of liver cirrhosis (15.3%) and 2 cases of hepatocellular carcinoma (16.6%).

Adolescent↗

Clinicobacteriological study of gas gangrene.

Out of 1040 cases of road side crush injuries 14 cases (1.3%) who developed gas gangrene clinically were studied bacteriologically. Clostridia accounted for 6 (42.86%) cases and non-clostridial anaerobes and aerobes for 4 (28.57%) cases each. Clostridium perfringens was found to be the commonest isolate but non-clostridial anaerobes and aerobes also formed a sizable number. It was concluded that for prevention of gas gangrene a proper surgical toilet and antibiotics at the time of injury were necessary and a smear examination might give a clue to early diagnosis.

Accidents, Traffic↗

Study of diphtheria carriers in Miraj.

Following a case of diphtheria, 131 contacts were studied for throat and nose carriage. The carriage of C. diphtheriae was found to be 19.8%, 65.3% of them were toxin producing by counter-immunoelectrophoresis (CIEP). The carriers were treated with erythromycin for 7 days. Repeat swabs found them to be negative for C. diphtheriae except in four who had erythromycin resistant and penicillin sensitive strains. Penicillin treatment eliminated the organisms.

Carrier State↗

Reporting systems for rare side effects of non-narcotic analgesics in India. Problems and opportunities.

Soon India will launch a fully developed system to monitor adverse drug reactions. The national requirement for this project encompasses 12 regional centres; district hospitals and primary health centres will be affiliated to these. Patient investigation and referrals will be manned by completely trained medical and paramedical personnel. The system is expected to become operational by 1987. Peculiar problems arise in the scientific research of adverse drug related events in India: illiteracy, the strong influence of traditional medicine, over-the-counter drug availability, inadequate numbers of trained personnel, shifting doctor-patient relations and costs. There is an opportunity for rigorous prospective epidemiological investigation in India, since the great majority of the population depends on governmental health support. Detailed drug-related events, timing of exposure and withdrawal can be accurately monitored. Various influential 'non-drug' factors relevant to the drug reaction must be considered in the assessment of any adverse drug reaction.

Analgesics↗

Bioequivalence studies in humans of indomethacin capsules marketed in India.

Two, separate 6 X 6 Latin square cross-over bioequivalence studies were performed in adult male volunteers using 10 different indomethacin capsule preparations marketed in India together with the pure drug powder as the standard. The products were evaluated with respect to plasma level at various times up to 8 h following administration of a 50 mg (2 X 25 mg) dose. Plasma samples were analysed by a fluorimetric method. Various pharmacokinetic parameters were calculated according to a two compartment model. Statistical evaluation of the data employed analysis of variance for a cross-over design (ANOVA) and Duncan's multiple range test to ascertain the significance of differences between the products. Of the 10 products studied, two were found to be bioinequivalent .

Adult↗

Effect of labetalol and propranolol on human cutaneous vasoconstrictor response to adrenaline.

Using half-life disappearance of intradermally injected radioiodine as a parameter for cutaneous blood flow, a study was made of the effects of labetalol and propranolol on the vasoconstrictor response to adrenaline at environmental temperatures of 22 degrees C and 32 degrees C in seven healthy volunteers. Iodine clearance was reduced at 22 degrees C, and at both temperatures by 16 pcg of adrenaline. Orally administered propranolol (20 mg) enhanced these effects at the lower temperature and that of adrenaline at both temperatures. This method unequivocally demonstrates the aggravation of adrenaline-induced cutaneous vasoconstriction caused by oral administration of propranolol and distinguishes it from that caused by labetalol.

Adult↗

Effects of labetalol and propranolol on responses to adrenaline infusion in healthy volunteers.

The effects of labetalol and propranolol were compared in eight healthy human volunteers using pulse rate and blood pressure changes in response to low rates of adrenaline infusion. Propranolol not only blocked but reversed the positive chronotropic and vasodepressor effects of adrenaline. Labetalol appeared to block these effects only partially. The alpha blocking property of labetalol may have contributed to this difference and hence is unlikely to cause alpha receptor mediated side-effects of endogenously released adrenaline in stress. This model is able to differentiate with great sensitivity between pure beta blockers and alpha beta blocking agents.

Adult↗

The physiologic availability of phenylbutazone tablets marketed in India.

The physiologic availability of five phenylbutazone formulations, all sugar-coated tablets, marketed in India was measured in a cross-over study with six healthy male volunteers by determining drug concentrations in plasma. Single doses of 100 mg were administered and pure drug powder was used as standard. Significant differences between the bioavailability of various products were determined despite large individual variations. Two formulations were found to give bioavailabilities of about 50% that of powder. Maximum concentrations of phenylbutazone in plasma appeared after 3-10 h depending on the preparation. Therapeutic differences in normal dosing schedule may be anticipated in case on the two poorly bioavailable products.

Adult↗